Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [18F]F-FDG PET/CT in Patients with Liver Malignancies
Conclusion[68 Ga]Ga-FAPI PET/CT with dedicated liver PET/MRI shows potential for superior detection of hepatic malignancy compared with [18F]FDG PET/CT or MRI alone.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research
More News: Bile Duct Cancer | Biology | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Molecular Biology | Study | Urology & Nephrology